Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Pregnant women with type 1 diabetes who used hybrid closed-loop insulin delivery with Control-IQ technology spent more time ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

Researchers at a recent American Diabetes Association meeting reported that efsitora, experimental once-weekly insulin, was comparable to daily insulins in nearly a thousand adults with type 2 ...

More than 8 million people globally suffer from type 1 diabetes, a condition where the immune system destroys ...

Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

In phase 2 of the FORWARD study, 83% of participants with type 1 diabetes achieved insulin independence a year after ...

During a clinical trial, around 83% (10 out of 12) of patients who received a full dose of Zimislecel achieved complete ...

An off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results, according to a new study.

Zimislecel, a novel stem cell therapy, has reportedly demonstrated promising results in an early-phase clinical trial ...